ENTRY       D06274                      Drug
NAME        Tafluprost (JAN/USAN/INN);
            Zioptan (TN)
PRODUCT     ZIOPTAN (Akorn)
            ZIOPTAN (Thea Pharma)
  GENERIC   TAFLUPROST (Micro Labs Limited)
            TAFLUPROST (Sandoz)
            TAFLUPROST (The Ritedose Corporation)
            TAFLUPROST OPHTHALMIC (Prasco Laboratories)
FORMULA     C25H34F2O5
EXACT_MASS  452.2374
MOL_WEIGHT  452.5313
CLASS       Hormonal agent
             DG01961  Prostaglandin derivative
              DG01960  Prostaglandin F derivative
            Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
REMARK      Therapeutic category: 1319
            ATC code: S01EE05
            Product: D06274<JP/US>
            Product (mixture): D10569<JP>
EFFICACY    Antiglaucoma, Prostaglandin F receptor agonist
  DISEASE   Open-angle glaucoma [DS:H00612]
COMMENT     Prostaglandin derivative
TARGET      PTGFR [HSA:5737] [KO:K04262]
  PATHWAY   hsa04020(5737)  Calcium signaling pathway
            hsa04080(5737)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
            map07228  Eicosanoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EE Prostaglandin analogues
                 S01EE05 Tafluprost
                  D06274  Tafluprost (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Intraocular Pressure Lowering Agents
               Prostaglandin and Prostamide Analogs, Ophthalmic
                Tafluprost
                 D06274  Tafluprost (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D06274  Tafluprost (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Hormonal agent
              DG01961  Prostaglandin derivative
               DG01960  Prostaglandin F derivative
                D06274  Tafluprost
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D06274  Tafluprost
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D06274  Tafluprost
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Prostaglandin
                PTGFR
                 D06274  Tafluprost (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D06274
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D06274
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D06274
DBLINKS     CAS: 209860-87-7
            PubChem: 47207932
            ChEBI: 66899
            LigandBox: D06274
ATOM        32
            1   C1x C    11.4193  -14.3979
            2   C1y C    12.2620  -15.5917
            3   C1y C    13.5962  -15.1704
            4   C1y C    13.5962  -13.7660
            5   C1y C    12.2620  -13.2744
            6   C1b C    14.7197  -12.9233
            7   C2b C    15.9837  -13.5553
            8   C2b C    17.3881  -13.5553
            9   C1b C    18.5819  -12.8531
            10  C1b C    19.8458  -13.5553
            11  C1b C    21.0397  -12.8531
            12  C7a C    22.2335  -13.4851
            13  O7a O    23.4272  -12.8531
            14  O6a O    22.2335  -14.8895
            15  C1c C    24.6210  -13.4851
            16  C1a C    25.8147  -12.8531
            17  C1a C    24.6210  -14.8895
            18  C2b C    14.7280  -16.0000
            19  C2b C    15.9588  -15.3520
            20  C1d C    17.1397  -16.0966
            21  C1b C    18.3557  -15.4569
            22  O2a O    19.5432  -16.2062
            23  X   F    16.1466  -17.0896
            24  X   F    18.1328  -17.0896
            25  C8y C    19.5432  -17.6107
            26  C8x C    18.3360  -18.3079
            27  C8x C    18.3360  -19.7123
            28  C8x C    19.5525  -20.4143
            29  C8x C    20.7597  -19.7171
            30  C8x C    20.7595  -18.3127
            31  O1a O    11.8642  -11.9275
            32  O1a O    11.8134  -16.9226
BOND        33
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     4   6 1 #Down
            7     6   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14   12  14 2
            15   13  15 1
            16   15  16 1
            17   15  17 1
            18    3  18 1 #Up
            19   18  19 2
            20   19  20 1
            21   20  21 1
            22   21  22 1
            23   20  23 1
            24   20  24 1
            25   22  25 1
            26   25  26 2
            27   26  27 1
            28   27  28 2
            29   28  29 1
            30   29  30 2
            31   25  30 1
            32    5  31 1 #Down
            33    2  32 1 #Down
///
